Blood glucose and cerebrovascular disease in nondiabetic patients

Angiology

Volumn 58, Issue 5, 2007, Pages 625-629

  Nielson, Christopher ^a,b,c,d   Fleming, Richard M ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b VA Sierra Nevada Health Care System   (United States)

^c St Luke's Boise Regional Medical Center   (United States)

^d Sierra Nevada Veterans Affairs Health Care System ^*  (United States)

Author keywords

Cerebrovascular disease; Diabetes; Glucose intolerance

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; BLOOD GLUCOSE; CIRCADIAN RHYTHM; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIERS ESTIMATE; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; UNITED STATES;

EID: 35448934454     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707303695     Document Type: Article

References (19)

1. Tuttolomondo A., Pinto A., Di RD, Fernandez P., Licata G.: Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 8: 581, 2005.
2. Vermeer SE, Sandee W., Algra A., Koudstaal PJ, Kappelle LJ, Dippel DW: Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke 37: 1413-1417, 2006.
3. Tanne D., Koren-Morag N., Goldbourt U.: Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke 35: 2351-2355, 2004.
4. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 27: S5 - S10, 2004.
5. Baron AD: Impaired glucose tolerance as a disease. Am J Cardiol 20: 16H - 9H, 2001.
6. Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 24: 447-53, 2001.
7. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC: Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 165: 227-233, 2005.
8. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G., Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 52: 20-28, 2002.
9. Hanefeld M., Temelkova-Kurktschiev T., Schaper F., Henkel E., Siegert G., Koehler C.: Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16: 212-218, 1999.
10. Hanefeld M.: Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness: a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus). Endocr Pract 12: 56-59, 2006.
11. Schriger DL, Lorber B.: Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? Diabetes Care 27: 592-601, 2004.
12. Singleton JR, Smith AG, Russell JW, Feldman EL: Microvascular complications of impaired glucose tolerance. Diabetes 52: 2867-2873, 2003.
13. Jorgensen L., Jenssen T., Joakimsen O., Heuch I., Ingebretsen OC, Jacobsen BK: Glycated hemoglobin level is strongly related to the prevalence of carotid artery plaques with high echogenicity in nondiabetic individuals: the Tromso study. Circulation 110: 466-470, 2004.
14. Nathan DM, Lachin J., Cleary P.,, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348: 2294-303, 2003.
15. Aronson D., Rayfield EJ: How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1: 1, 2002.
16. Vehkavaara S., Seppala-Lindroos A., Westerbacka J., Groop PH, Yki-Jarvinen H.: In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care 22: 2055-2060, 1999.
17. Festa A., Hanley AJ, Tracy RP, D'Agostino R., Jr., Haffner SM: Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108: 1822-1830, 2003.
18. Carr ME: Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 15: 44-54, 2001.
19. Esposito K., Giugliano D., Nappo F., Marfella R.: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110: 214-219, 2004.